Home › Funds › Boxer Capital Management, LLC › APGE

Boxer Capital Management, LLC position in APGE

APOGEE THERAPEUTICS INC

Boxer Capital Management, LLC reported holding 70,000 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.3M, representing 0.70% of its reported portfolio and ranking #26 among its reported holdings. Boxer Capital Management, LLC has disclosed APGE holdings in 5 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)70.00K sh
Reported value held$9.29M
Portfolio Weight0.70%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Boxer Capital Management, LLC's APGE position evolved

Boxer Capital Management, LLC first disclosed a stake in APGE in Q4 2024 at 86,000 shares (US$3.9M). The position peaked in Q2 2026 at 70,000 shares, worth US$9.3M. Across 5 filings, Boxer Capital Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 70,000 shares valued at US$9.3M. Notable position changes include a 40% increase in Q4 2025.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 86.00K $3.90M New
Q3 2025 50.00K $1.99M New
Q4 2025 70.00K $5.28M Add
Q1 2026 70.00K $5.89M Hold
Q2 2026 70.00K $9.29M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →

FAQ

How long has Boxer Capital Management, LLC held APGE?

Boxer Capital Management, LLC has disclosed APGE holdings in 5 of the last 7 reported quarters, going back to Q4 2024.

What is Boxer Capital Management, LLC's current position in APGE?

As of Q2 2026, Boxer Capital Management, LLC holds 70.00K shares of APGE (APOGEE THERAPEUTICS INC), valued at $9.29M, representing 0.70% of its reported portfolio and ranking #26.

Has Boxer Capital Management, LLC been buying or selling APGE?

In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in APGE. The position peaked in Q2 2026 at 70.00K shares.

Which other funds hold APGE?

Other major institutional holders of APGE include Venrock Adviser, LLC, HBK INVESTMENTS L P, DRIEHAUS CAPITAL MANAGEMENT LLC, among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.